Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

NCT01033760 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infections

Interventions

DRUG: raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine
DRUG: darunavir; ritonavir; emtricitabine/tenofovir

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]